C12Q 1/70
Involving virus or bacteriophage
Official title: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
C12Q1/70 (Involving virus or bacteriophage) appears on 3,324 US grants and 4,800 published applications in this corpus.
Search patents in C12Q- Granted patents
- 3,324
- Published applications
- 4,800
- Assignees
- 2,183
- Inventors
- 9,751
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 7 | 0 |
| 1985 | 5 | 0 |
| 1986 | 5 | 0 |
| 1987 | 6 | 0 |
| 1988 | 13 | 0 |
| 1989 | 17 | 0 |
| 1990 | 15 | 0 |
| 1991 | 25 | 0 |
| 1992 | 25 | 0 |
| 1993 | 36 | 0 |
| 1994 | 29 | 0 |
| 1995 | 42 | 0 |
| 1996 | 82 | 0 |
| 1997 | 95 | 0 |
| 1998 | 108 | 0 |
| 1999 | 95 | 0 |
| 2000 | 85 | 0 |
| 2001 | 103 | 20 |
| 2002 | 79 | 118 |
| 2003 | 94 | 178 |
| 2004 | 59 | 151 |
| 2005 | 66 | 182 |
| 2006 | 60 | 163 |
| 2007 | 70 | 164 |
| 2008 | 87 | 136 |
| 2009 | 84 | 190 |
| 2010 | 100 | 174 |
| 2011 | 88 | 160 |
| 2012 | 91 | 167 |
| 2013 | 94 | 163 |
| 2014 | 99 | 198 |
| 2015 | 91 | 209 |
| 2016 | 115 | 189 |
| 2017 | 135 | 188 |
| 2018 | 144 | 182 |
| 2019 | 151 | 188 |
| 2020 | 139 | 157 |
| 2021 | 134 | 259 |
| 2022 | 113 | 258 |
| 2023 | 94 | 363 |
| 2024 | 93 | 281 |
| 2025 | 123 | 208 |
| 2026 | 116 | 154 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Detection and prediction of infectious disease6 Oct 2026US 12,753,448 B2Karius, Inc.
- Coronavirus detection6 Oct 2026US 12,753,450 B2Diagnostics for the Real World, Ltd.
- Method for determining active SARS-CoV-2-infections6 Oct 2026US 12,753,451 B2Ceinge Biotecnologie Avanzate Franco Salvatore S.C. A R.L.
- Magnetic tunnel junction based molecular spintronics device and magnetic resonance sensors6 Oct 2026US 12,755,883 B2University of the District of Columbia
- Methods for determination of transplant rejection29 Sep 2026US 12,747,480 B2Natera, Inc.
- Replicon dna, cloning vector, screening kit, screening method, anti-nobecov-irus agent, beta-coronavirus proliferation inhibitor, pan beta-coronavirus inhibitor, virus proliferation inhibitor, hepatitis c virus proliferation inhibitor, and method for screening therapeutic agent for viral infectious disease8 Oct 2026US 2026/0308206 A1Kagoshima University
- Crispr-cas-based novel guide rna capable of specific detection of norovirus gii.4 and application thereof8 Oct 2026US 2026/0308703 A1Pulmuone Co., Ltd.
- Systems, methods, and apparatus for automated self-contained biological analysis1 Oct 2026US 2026/0295577 A1PLC Diagnostics, Inc.
- Fret-based analytes detection and related methods and systems1 Oct 2026US 2026/0297675 A1California Institute of Technology
- One-tube rt-qpcr fully premixed reaction reagent, use, and rt-qpcr method1 Oct 2026US 2026/0297691 A1Shanghai Biogerm Medical Technology Co., Ltd.
Most cited
By later US patents
- Homogeneous assay system using the nuclease activity of a nucleic acid polymerase907US 5,210,015 AHoffman-La Roche Inc. · 1993
- Nucleic acid multimers and amplified nucleic acid hybridization assays using same674US 5,124,246 AChiron Corporation · 1992
- Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved663US 5,403,711 AUniversity of Iowa Research Foundation · 1995
- Oligonucleotides having phosphorothioate linkages of high chiral purity626US 5,587,361 AIsis Pharmaceuticals, Inc. · 1996
- Homogeneous methods for nucleic acid amplification and detection623US 5,994,056 ARoche Molecular Systems, Inc. · 1999